Stay updated on UBX1325 Safety in Macular Disease Clinical Trial

Sign up to get notified when there's something new on the UBX1325 Safety in Macular Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UBX1325 Safety in Macular Disease Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now presents the study record for the UBX1325 Phase 1 safety and tolerability trial in patients with diabetic macular edema or neovascular age-related macular degeneration, including its study details and participant criteria.
    Difference
    41%
    Check dated 2026-11-09T14:30:31.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the displayed study record still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:16:52.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a website transition and says some NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T16:07:47.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T20:59:51.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer’s revision number changed from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T04:07:30.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The study page displays a 403 Forbidden message with a Home link instead of study information.
    Difference
    0.5%
    Check dated 2026-10-05T20:32:36.000Z thumbnail image

Stay in the know with updates to UBX1325 Safety in Macular Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UBX1325 Safety in Macular Disease Clinical Trial page.